Total Payments
$8,499
2024 Payments
$674.78
Companies
42
Transactions
528
Medicare Patients
2,653
Medicare Billing
$37,385
Payment Breakdown by Category
Food & Beverage$8,222 (96.7%)
Education$276.56 (3.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,222 | 519 | 96.7% |
| Education | $276.56 | 9 | 3.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,252 | 51 | $0 (2024) |
| Lilly USA, LLC | $1,022 | 66 | $0 (2024) |
| Novo Nordisk Inc | $975.01 | 57 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $883.59 | 51 | $0 (2024) |
| Amarin Pharma Inc. | $500.46 | 35 | $0 (2022) |
| Astellas Pharma US Inc | $424.44 | 18 | $0 (2023) |
| Amgen Inc. | $376.80 | 27 | $0 (2024) |
| PFIZER INC. | $343.50 | 40 | $0 (2021) |
| Ironwood Pharmaceuticals, Inc | $297.20 | 21 | $0 (2022) |
| Merck Sharp & Dohme LLC | $251.59 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $674.78 | 39 | Amgen Inc. ($152.60) |
| 2023 | $661.93 | 31 | Lilly USA, LLC ($223.11) |
| 2022 | $647.96 | 39 | AstraZeneca Pharmaceuticals LP ($179.77) |
| 2021 | $1,278 | 81 | Lilly USA, LLC ($215.17) |
| 2020 | $1,051 | 67 | Amarin Pharma Inc. ($186.84) |
| 2019 | $994.79 | 80 | PFIZER INC. ($187.17) |
| 2018 | $1,790 | 115 | Novo Nordisk Inc ($347.19) |
| 2017 | $1,400 | 76 | AstraZeneca Pharmaceuticals LP ($243.45) |
All Payment Transactions
528 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: PSYCHIATRY | ||||||
| 11/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $22.99 | General |
| Category: Oncology | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: Inflammation | ||||||
| 10/03/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $13.84 | General |
| Category: Cardio-renal | ||||||
| 09/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $6.91 | General |
| Category: Inflammation | ||||||
| 09/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $28.02 | General |
| Category: Cardiology | ||||||
| 09/05/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Oncology | ||||||
| 09/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug), TRADJENTA, JARDIANCE | Food and Beverage | In-kind items and services | $20.62 | General |
| Category: DIABETES | ||||||
| 08/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Inflammation | ||||||
| 08/27/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: VACCINE | ||||||
| 08/09/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Pulmonology | ||||||
| 07/24/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Inflammation | ||||||
| 07/02/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Diabetes | ||||||
| 06/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.01 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 403 | 629 | $30,845 | $5,554 |
| 2022 | 12 | 597 | 927 | $47,765 | $9,185 |
| 2021 | 16 | 786 | 1,143 | $57,310 | $11,105 |
| 2020 | 13 | 867 | 1,226 | $60,770 | $11,541 |
Total Patients
2,653
Total Services
3,925
Medicare Billing
$37,385
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 61 | 69 | $5,465 | $1,136 | 20.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 68 | 85 | $5,320 | $1,115 | 21.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 40 | 103 | $4,150 | $980.56 | 23.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 65 | 86 | $6,820 | $886.25 | 13.0% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 45 | 147 | $2,535 | $565.95 | 22.3% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2023 | 53 | 59 | $2,770 | $374.06 | 13.5% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 15 | 18 | $770.00 | $159.12 | 20.7% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 13 | 16 | $770.00 | $132.64 | 17.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 21 | 21 | $1,330 | $118.86 | 8.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 22 | 25 | $915.00 | $85.25 | 9.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 89 | 109 | $8,175 | $1,794 | 21.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 94 | 124 | $7,440 | $1,629 | 21.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 50 | 142 | $7,100 | $1,354 | 19.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 95 | 126 | $9,450 | $1,306 | 13.8% |
| 82947 | Blood glucose (sugar) level | Office | 2022 | 53 | 180 | $2,700 | $694.67 | 25.7% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 13 | 13 | $1,950 | $660.35 | 33.9% |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | Office | 2022 | 82 | 93 | $4,185 | $594.94 | 14.2% |
| 82306 | Vitamin d-3 level | Office | 2022 | 14 | 14 | $1,400 | $408.78 | 29.2% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 20 | 22 | $880.00 | $196.10 | 22.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2022 | 34 | 34 | $2,040 | $193.76 | 9.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2022 | 16 | 23 | $1,035 | $191.96 | 18.5% |
| 81002 | Urinalysis, manual test | Office | 2022 | 37 | 47 | $1,410 | $161.69 | 11.5% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 109 | 140 | $8,400 | $1,863 | 22.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2021 | 92 | 110 | $8,250 | $1,833 | 22.2% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 61 | 159 | $7,950 | $1,518 | 19.1% |
About Dr. Daniel Domjan, MD
Dr. Daniel Domjan, MD is a Acupuncturist healthcare provider based in Sikeston, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235119215.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Domjan, MD has received a total of $8,499 in payments from pharmaceutical and medical device companies, with $674.78 received in 2024. These payments were reported across 528 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,222).
As a Medicare-enrolled provider, Domjan has provided services to 2,653 Medicare beneficiaries, totaling 3,925 services with total Medicare billing of $37,385. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Acupuncturist
- Other Specialties General Practice
- Location Sikeston, MO
- Active Since 01/18/2006
- Last Updated 03/12/2020
- Taxonomy Code 171100000X
- Entity Type Individual
- NPI Number 1235119215
Products in Payments
- JARDIANCE (Drug) $604.02
- FARXIGA (Drug) $516.79
- Vascepa (Drug) $500.46
- TRULICITY (Drug) $455.10
- TRADJENTA (Drug) $398.29
- Ozempic (Drug) $367.19
- SYMBICORT (Drug) $282.36
- Victoza (Drug) $244.07
- BREZTRI (Drug) $236.73
- Tresiba (Drug) $209.75
- Linzess (Drug) $204.75
- Kerendia (Drug) $181.19
- EMGALITY (Drug) $175.06
- Otezla (Drug) $167.87
- Livalo (Drug) $164.22
- VRAYLAR (Drug) $153.67
- LYRICA (Drug) $153.44
- SOLIQUA (Drug) $149.10
- BELSOMRA (Drug) $138.88
- MOUNJARO (Drug) $137.95
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.